Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,740 | -1,190 | -1,040 | -360 | -1,200 |
| Depreciation Amortization | 0 | 50 | 0 | 0 | 90 |
| Other Working Capital | 0 | 10 | 0 | 0 | -280 |
| Other Operating Activity | 240 | 40 | 420 | 80 | 80 |
| Operating Cash Flow | $-1,500 | $-1,090 | $-620 | $-280 | $-1,310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -2 | -1 | 0 | -10 |
| Net Acquisitions | 730 | 730 | 0 | 0 | 0 |
| Other Investing Activity | -1,924 | -1,208 | -639 | 980 | -1,360 |
| Investing Cash Flow | $-1,200 | $-480 | $-640 | $980 | $-1,370 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,280 | 4,200 | 3,800 | 3,770 | 1,740 |
| Financing Cash Flow | $4,280 | $4,200 | $3,800 | $3,770 | $1,740 |
| Exchange Rate Effect | 5 | -30 | -30 | 20 | -3 |
| Beginning Cash Position | 120 | 120 | 120 | 120 | 1,060 |
| End Cash Position | 1,690 | 2,700 | 2,620 | 4,610 | 120 |
| Net Cash Flow | $1,570 | $2,580 | $2,500 | $4,490 | $-940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,500 | -1,090 | -620 | -280 | -1,310 |
| Free Cash Flow | -1,500 | -1,090 | -620 | -280 | -1,310 |